Chapters covered: 33 (pg 887-896), 50 (pg 1526-1529, 1536-1537)
Copyright © 2023 by Elsevier Inc. All rights reserved.
Immunization: Essential for preventing outbreaks of infectious diseases, immunizations should be updated according to CDC recommendations to ensure high levels of community immunity. Vaccines have been instrumental in reducing the incidence of many infectious diseases and contribute to the overall health of the population.
Controlling Spread of Disease:
Reducing risk of cross-transmission of organisms through measures such as social distancing, use of personal protective equipment (PPE), and quarantine when necessary.
Implementing infection control policies in schools and child care settings to minimize risk of outbreaks.
Importance of hand hygiene: Regular hand washing with soap and water for at least 20 seconds, or the use of alcohol-based hand sanitizers when soap is unavailable, is critical in preventing the spread of infections among children.
Immunodeficiency: Individuals with weakened immune systems, whether due to congenital factors, chronic diseases, or medication-induced compromise, are at higher risk for severe infections.
Generalized Malignancies: Children undergoing treatment for cancer, especially those receiving chemotherapy or radiation, have weakened immune systems and are particularly vulnerable to infections.
Immunologic Disorders: Conditions such as systemic lupus erythematosus or autoimmune disorders can impact immune responses and increase susceptibility to infections.
Infants Younger than 1 Year: This age group is at heightened risk for infections due to immature immune systems and lack of prior exposure to pathogens. Vaccination schedules are crucial during this time.
Hemolytic Disease: Increased risk for complications in specific disorders, such as sickle cell disease or other hemoglobinopathies, where infections can lead to significant morbidity and mortality.
Chickenpox (varicella)
Diphtheria
Fifth disease (Erythema infectiosum)
Roseola infantum (Exanthem Subitum)
Mumps
Measles (rubeola)
Pertussis (whooping cough)
Poliomyelitis
Rubella (German measles)
Scarlet fever
Agent: Caused by the varicella-zoster virus (VZV), a member of the herpes virus family.
Spread: Primarily through direct contact with rash lesions, respiratory droplets from coughing or sneezing, airborne, and contact with contaminated objects.
Incubation Period: 2 to 3 weeks (usually between 14 to 16 days).
Communicability: Highly contagious; can be transmitted from 1-2 days before the onset of the rash until all lesions have crusted over.
1 to 2 days before lesions appear until all lesions have formed crusts
Clinical Manifestations:
Prodromal stage: Symptoms include low-grade fever, fatigue, loss of appetite, and headache, which may last 1-2 days.
Characteristic pruritic rash: Progresses from macule to papule to vesicle to crusting; rash typically starts on the trunk and then spreads to the face and extremities.
distribution: starts in the center of the trunk, spreads to the face, and proximal extremities
Duration: About 1 week for all lesions to crust.
Complications: Include pneumonia, bleeding disorders, bacterial superinfection of skin lesions, and encephalitis.
Management:
Antiviral agents such as Acyclovir are recommended for high-risk patients.
Antihistamines may help relieve itching.
diphenhydramine hydrochloride (benadryl)
NSAID to reduce fever
Proper skin care to prevent secondary bacterial infections is crucial.
Vaccination recommendations include the varicella vaccine at age 12-15 months, with a booster between 4-6 years.
maintain isolation precautions
keep child away from high-risk ppl until vesicles have dried (usually 1 wk from onset)
keep cool and administer topical calamine lotion as needed
teach to apply pressure instead of scratching
keep nails clean and short, and apply mittens if the child scratches
change linens daily
Agent: Caused by the bacterium Corynebacterium diphtheriae.
Spread: Transmitted through direct contact with a person-to-person via respiratory droplets.
Incubation Period: Typically 2 to 5 days.
Clinical Manifestations: Symptoms vary based on the infection site:
Nasal diphtheria resembles the common cold with nasal discharge.
Tonsillar-pharyngeal involves a sore throat, low-grade fever, tachycardia, loss of appetite, lymphadenitis (bulls neck), and the formation of a characteristic grayish-white membrane in the throat. In severe cases, death within 6-10 days
Laryngeal diphtheria presents with fever, hoarseness, and stridor, posing a risk for airway obstruction.
Complications: Serious complications include myocardial damage (cardiomyopathy between 2 to 3 wks), peripheral neuropathy, and airway obstruction due to swelling.
Therapeutic Management:
Administration of equine antitoxin is indicated
antibiotics such as Penicillin G or Erythromycin to eradicate the bacteria.
Complete bed rest to prevent myocarditis
Tracheostomy for airway obstruction
treat exposed contacts
follow isolation precautions until negative for C. Diphtheriae
2 negative cultures and use contact precautions
suctioning & humidified oxygen as needed
Agent: Caused by Parvovirus B19.
Spread: Primarily through respiratory droplets and blood.
Incubation: 4 to 14 days, up to 21 days
Communicability: onset of manifestations before rash appears
Clinical Manifestations:
stage 1: erythema on face, chiefly on cheeks (slapped face appearance); disappears by 1-4 days
stage 2: about 1 day after rash appears on face, maculopapular red spots appear, symmetrically distributed on upper and lower extremities; rash progresses from proximal to distal surfaces and may last > 1 week
stage 3- rash subsides but reappears if skin is irritated or traumatized (sun, heat, cold, friction)
secondary itchy rash that can appear on the rest of the body, especially on the soles of the feet
Complications:
self-limited arthritis and arthralgia (arthritis may become chronic); more common in adult women
may result in serious complications (anemia, hydrops) or fetal death if the mother is infected during pregnancy (primarily 2nd trimester)
Children with immunodeficient or chronic red blood cell disorders (such as sickle cell anemia) may develop severe anemia with the 5th disease
myocarditis (rare)
Nursing care management
isolation is not necessary
Agent: Caused by Human Herpesvirus type 6/7.
Spread: Transmitted via the saliva of a healthy adult person, entry via nasal, buccal, or conjunctival mucosa. In most cases, have no contact with an infected person. limited to children < 3 yrs with peak at 6 to 15 months
incubation: 5 to 15 days
communicability: unknown
complications: recurrent febrile seizures & encephalitis
Clinical Manifestations:
High fever (sometimes > 104°F),
followed by a rash after the fever resolves. The rash is typically less pruritic and lasts 1-2 days.
bulging fontanel
Therapeutic management
nonspecific, antipyretics
Management:
standard precations
Education on fever control (antipyretic)
seizure precautions ifthe child is prone to having
Agent: Caused by the Paramyxovirus.
Spread: Primarily through direct contact and respiratory droplets.
Incubation Period: Ranges from 14 to 21 days.
communicability: immediately before and after swelling begins
Clinical Manifestations:
painful, swollen parotid glands
fever & muscle aches
headaches
earache made worse by chewing
fatigue & loss of appetite
Complications: Serious complications may include orchitis, deafness, encephalitis, oophoritis, mastitis, myocarditis, arthritis, hepatitis, and viral meningitis.
Management:
therapeutic management
Symptomatic & supportive: analgesics for pain and antipyretics for fever
IV fluids if needed for child who refuses to drink or vomits because of meningoencephalitis
Maintain isolation during the communicability period
Encourage rest and decreased activity
Analgesica for pain; if the child is unwilling to swallow pills or tablet med use the elixir form
to relieve orchitis, provide hot or cold packs for analgesia, and scrotal elevation
Encourage fluids and bland foods
hot or cold compresses to the neck
Agent: Caused by the Rubeola virus.
Spread: Highly contagious, spread through contact and respiratory droplets.
incubation: 10 to 20 days
Clinical Manifestations:
3 to 4 days before rash
mild to moderate fever, conjunctivitis, fatigue, cough, runny nose, red eyes, & sore throat
Rash
Koplik spots (tiny white spots) appear in the mouth 2 days before the rash, red or reddish- brown rash beginning on the face spreading downward, spike in fever with rash
Complications: Common complications include ear infections, pneumonia, encephalitis, death, and laryngitis
Therapeutic Management:
supportive; bed rest and antipyretics, childhood immunization
antibiotics to prevent secondary infections in high-risk children, and vitamin A (dose based on age)
isolation until 5th day of rash
encourage rest and fever control, along with seizure precautions if at risk for seizures
eye care- dim light if photophobia present; clean eyelids with warm saline solution to remove secretions or crusts
cough control with a cool mist vaporizer
Agent: Caused by Bordetella pertussis.
Spread: Transmitted via contact and respiratory droplets. Indirect contact with freshly contaminated articles
incubation: 7 to 10 days
communicability: greatest during the catarrhal stage before the onset of the paroxysmal stage
Clinical Manifestations:
common cold manifestations: runny nose/ congestion, sneezing, mild fever, mild cough
severe coughing starts in 1 to 2 wks: coughing fits, violent & rapid coughing, loud “whooping” sound upon inspiration
Complications: Serious complications can include pneumonia, seizures, apnea, encephalopathy, death, ear infections (otitis media), hemorrhage, weight loss and hernia
teens and adults: weight loss, loss of bladder control, syncope, rib fractures, pneumonia
Management:
maintain isolation during the catarrhal stage; if the child is hospitalized, standard and droplet (standard and droplet precautions)
antibiotic therapy: (erythromycin, clarithromycin, azithromycin)
supportive care:
hospitalization is sometimes required for infants who are dehydrated, increased O2 intake, and humidity, adequate fluids
Encourage adolescents to obtain Tdap
nasopharyngeal culture for diagnosis
Agent: Caused by the Rubella virus.
Spread: Transmitted through contact and respiratory droplets.
incubation: 14 to 21 days
communicability: 7 days before to 5 days after the rash appears
Clinical Manifestations:
low-grade fever and sore throat
headache
malaise
cough
lymphadenopathy
red rash that starts on the face and spreads to the rest of the body, lasting 2 to 3 days
Complications:
generally are. can cause birth defects in the fetus of infected women during pregnancy.
therapeutic management
no treatment needed other than antipretics and analgesics
nursing care management
maintain droplet isolation
reassure parents of the benign nature of illness
comfort measures
avoid contact with preg woman
monitor rubella titler in preg adolescents
Agent: Caused by Group A beta-hemolytic streptococci (S. pyogenes).
Spread: Transmitted via direct contact, droplet, and ingestion of contaminated food (milk)
incubation: 2 to 5 days with a range of 1 to 7 days
communicability: incubation period& clinical illness approximately 10 days: during 1st 2 wks of the carrier phase but may persist months.
Clinical Manifestations:
prodromal stages: abrupt high fever; tachycardia; vomiting; headache; halitosis; abdominal pain
enanthema: enlarged tonsilis; edematous , reddended, and covered with patches of exudates; pharynx edematous and beefy red: during day 1 and 2 tongue coated and papillaebecomes red & swollen (white strawberry tongue), by 4th or 5th day white coat sloughs off leaving prominent papilae (red strawberry tongue)
exanthema: rash appears within 12 hrs after prodromal signs; red pin-head-sized punctate lesions become generalized but absent from face; face flushed with circumoral pallor; rash more prominent on a fold of joints.
end of 1st wk, desquamation begins and is typically complete by wk 3.
Complications:
peritonsillar & retropharyngeal abscess, otitis media, acute glomerulonephritis, acute RF,
Management:
standard and droplet precautions until 24 h after initiation of treatment
ensure compliance with oral antibiotics therapy (IM benzathine Penicillin G )
rest during febrile phase, analgesis for sore throat; antipruritics for rash if bothersome
encourage fluids during the febrile phase; avoid irritating liquids (citrus juices) or rough foods (chips); when child can eat, begin with a soft diet
Discard the toothbrush; avoid sharing drinking and eating utensils
identify etiological agents or agents
issues with the development of different strains that are resistant to antibiotic therapies
prompt treatment with effective therapies
using health promotion behaviors to prevent the spread of infection
compliance with established therapies
prevent complications
Viral Infections:
leads to inflammation or proliferation
many communicable diseases present with a characteristic rash
Prevention of transmission
isolation procedures
antiviral meds
Fungal Infections:
identified dermatophytoses
can present in various locations of the body, can be localized and/or systemic
Prevention of transmission
hygiene procedures
should not exchange grooming items, headgear, scarves, or other articles of apparel that have been affected, and provide their own towel.
antifungal meds (terbinafine, itraconazole, and fluconazole)
Description: An inflammatory reaction of the skin to chemical substances, natural, or synthetic materials that evoke a hypersensitivity response or direct irritation
clinical manifestations
sharp demarcation between inflamed and normal skin on an erythematous base.
persistent pruritus
Management:
primary goal is to prevent further exposure of the skin to the offending agent
most commonly plants, animals, metal irritants, convex surfaces of diaper area, vegetable irritants, synthetic fabrics and dyes, cosmetics, perfumes, and soaps
Pruritus: most common complaint with skin lesions
cooling baths or compresses
prevent scratching
mittens/covering for young kids
short nails
antipruritic meds
Diphenhydramine hydrochloride and hydroxyzine are most commonly used
Description: endemic infection by the scabies mite
Clinical manifestations: maculopapular lesions distributed in intertriginous areas. Monitor for discrete papules, burrows or vesicles
high degree of transmission through prolonged close personal contact
Management:
anyone in close contact with the child needs treatment
treat with a scabicide
permethrin 5% (elemite) when older than 2 months
10% crotamiton (cream or lotion or oral ivermectin
Avoid the use of lindane
Danger of neurotoxicity
infestation that can occur in multiple areas of the body, common in school-age kids
high degree of transmission
eggs hatch in 7 to 10 days
white eggs are nits
treatment
permethrin 1% cream (nix)
pyrethrin (rid)
Remove nit cases
prevent the spread of lice
continued inspection
isolation of self-care products for the individual
machine wash hot water and dryer for involved contact products (sheets, pillowcases, and blankets)
removal of non-washable items or sealing in a plastic bag for at least 14 days
follow through with med therapy
family education